Start Venture

START (South Texas Accelerated Research and Therapeutics) is a leading global clinical research organization specializing in Phase I oncology drug development. The company operates one of the world's largest networks of Phase I clinical trial sites, providing pharmaceutical and biotechnology companies with efficient access to patient populations and expert clinical investigators. START's mission is to accelerate the development of new anticancer drugs by conducting high-quality, early-phase clinical trials that bridge the gap between laboratory research and clinical application. With facilities in the United States and Europe, the organization plays a critical role in the initial human testing of many of the most promising new cancer therapies in the industry pipeline.